Cite
HARVARD Citation
Higuchi, T. et al. (n.d.). SAT0139 Maximum Methotrexate Dose Seem To Be An Only Risk Factor for Development of MTX-Associated Lymphoproliferative Disorders. Annals of the rheumatic diseases. pp. 714-715. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Higuchi, T. et al. (n.d.). SAT0139 Maximum Methotrexate Dose Seem To Be An Only Risk Factor for Development of MTX-Associated Lymphoproliferative Disorders. Annals of the rheumatic diseases. pp. 714-715. [Online].